Marshall Wace’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $224M | Sell |
3,689,838
-7,154,432
| -66% | -$417M | 0.22% | 67 |
|
|
2025
Q4 | $585M | Buy |
10,844,270
+9,310,682
| +607% | +$448M | 0.53% | 21 |
|
|
2025
Q3 | $69.2M | Buy |
1,533,588
+1,528,823
| +32,084% | +$71.4M | 0.07% | 249 |
|
|
2025
Q2 | $221K | Buy |
+4,765
| New | +$234K | ﹤0.01% | 2431 |
|
|
2024
Q4 | – | Sell |
-868,109
| Closed | -$44.9M | – | 2594 |
|
|
2024
Q3 | $44.9M | Buy |
868,109
+612,379
| +239% | +$28.7M | 0.05% | 309 |
|
|
2024
Q2 | $10.6M | Sell |
255,730
-618,454
| -71% | -$27.7M | 0.01% | 704 |
|
|
2024
Q1 | $47.4M | Buy |
+874,184
| New | +$44.5M | 0.07% | 270 |
|
|
2023
Q4 | – | Sell |
-339,352
| Closed | -$19.7M | – | 2197 |
|
|
2023
Q3 | $19.7M | Sell |
339,352
-1,595,177
| -82% | -$97.7M | 0.04% | 445 |
|
|
2023
Q2 | $124M | Buy |
+1,934,529
| New | +$130M | 0.24% | 79 |
|
|
2023
Q1 | – | Sell |
-63,721
| Closed | -$4.58M | – | 2674 |
|
|
2022
Q4 | $4.58M | Buy |
+63,721
| New | +$4.8M | 0.01% | 1240 |
|
|
2022
Q2 | – | Sell |
-57,620
| Closed | -$4.21M | – | 3434 |
|
|
2022
Q1 | $4.21M | Buy |
57,620
+50,100
| +666% | +$3.36M | 0.01% | 1497 |
|
|
2021
Q4 | $469K | Buy |
7,520
+1,362
| +22% | +$79.9K | ﹤0.01% | 2835 |
|
|
2021
Q3 | $365K | Sell |
6,158
-51,576
| -89% | -$3.4M | ﹤0.01% | 2555 |
|
|
2021
Q2 | $3.86M | Sell |
57,734
-688,291
| -92% | -$44.9M | 0.02% | 1000 |
|
|
2021
Q1 | $47.1M | Sell |
746,025
-471,700
| -39% | -$29.3M | 0.22% | 88 |
|
|
2020
Q4 | $75.5M | Buy |
1,217,725
+847,514
| +229% | +$52.1M | 0.41% | 45 |
|
|
2020
Q3 | $22.3M | Sell |
370,211
-75,075
| -17% | -$4.52M | 0.14% | 154 |
|
|
2020
Q2 | $26.2M | Buy |
445,286
+433,882
| +3,805% | +$26M | 0.18% | 126 |
|
|
2020
Q1 | $636K | Sell |
11,404
-28,177
| -71% | -$1.72M | 0.01% | 918 |
|
|
2019
Q4 | $2.54M | Sell |
39,581
-70,306
| -64% | -$4.03M | 0.02% | 736 |
|
|
2019
Q3 | $5.57M | Buy |
109,887
+33,361
| +44% | +$1.57M | 0.04% | 476 |
|
|
2019
Q2 | $3.47M | Sell |
76,526
-60,463
| -44% | -$2.82M | 0.03% | 603 |
|
|
2019
Q1 | $6.54M | Sell |
136,989
-630,878
| -82% | -$31.4M | 0.06% | 388 |
|
|
2018
Q4 | $39.9M | Sell |
767,867
-99,754
| -11% | -$5.36M | 0.41% | 44 |
|
|
2018
Q3 | $53.9M | Buy |
867,621
+140,539
| +19% | +$8.34M | 0.46% | 37 |
|
|
2018
Q2 | $40.2M | Buy |
727,082
+674,457
| +1,282% | +$36.4M | 0.6% | 39 |
|
|
2018
Q1 | $3.33M | Sell |
52,625
-250,968
| -83% | -$16.1M | 0.14% | 140 |
|
|
2017
Q4 | $18.6M | Buy |
303,593
+215,335
| +244% | +$13.5M | 0.78% | 30 |
|
|
2017
Q3 | $5.65M | Buy |
+88,258
| New | +$5.15M | 0.26% | 84 |
|
|
2017
Q2 | – | Sell |
-30,433
| Closed | -$1.64M | – | 319 |
|
|
2017
Q1 | $1.64M | Sell |
30,433
-482,749
| -94% | -$26.5M | 0.08% | 171 |
|
|
2016
Q4 | $30M | Sell |
513,182
-429,198
| -46% | -$23.5M | 0.2% | 138 |
|
|
2016
Q3 | $50.8M | Buy |
942,380
+355,452
| +61% | +$22.8M | 0.36% | 67 |
|
|
2016
Q2 | $43.2M | Sell |
586,928
-268,987
| -31% | -$19M | 0.36% | 64 |
|
|
2016
Q1 | $54.7M | Sell |
855,915
-1,977,838
| -70% | -$125M | 0.53% | 51 |
|
|
2015
Q4 | $195M | Buy |
2,833,753
+1,798,080
| +174% | +$119M | 1.83% | 3 |
|
|
2015
Q3 | $61.3M | Buy |
1,035,673
+389,607
| +60% | +$24.7M | 0.75% | 25 |
|
|
2015
Q2 | $43M | Sell |
646,066
-189,281
| -23% | -$12.5M | 0.56% | 42 |
|
|
2015
Q1 | $53.9M | Buy |
835,347
+804,386
| +2,598% | +$50.4M | 0.7% | 20 |
|
|
2014
Q4 | $1.83M | Sell |
30,961
-543,104
| -95% | -$30.6M | 0.02% | 473 |
|
|
2014
Q3 | $29.4M | Buy |
+574,065
| New | +$28.7M | 0.42% | 55 |
|
|
2014
Q2 | – | Sell |
-208,145
| Closed | -$10.8M | – | 931 |
|
|
2014
Q1 | $10.8M | Buy |
+208,145
| New | +$11.1M | 0.2% | 138 |
|
Other funds holding BMY
VCM
VPM
Marshall Wace's BMY Position: Q1 2026 in Review
Marshall Wace reduced its Bristol-Myers Squibb (BMY) stake by 66% in Q1 2026, selling an estimated $417M and leaving 3,689,838 shares worth $224M. The position accounts for 0.22% of the portfolio, ranked #67.
Marshall Wace first reported a position in BMY in Q1 2014 and has held it in 41 quarters since. The position peaked at $585M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Marshall Wace held 3,689,838 shares of Bristol-Myers Squibb worth $224M as of Q1 2026.
- Marshall Wace sold 7,154,432 Bristol-Myers Squibb shares in Q1 2026, an estimated $417M.
- Bristol-Myers Squibb made up 0.22% of Marshall Wace's portfolio in Q1 2026, its #67 holding.
- Marshall Wace first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 41 quarters since.
- Marshall Wace's Bristol-Myers Squibb position peaked at $585M in Q4 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.